Pfizer's Covid-19 vaccine may cost less than $10 a dose in India
US pharmaceutical major Pfizer may price its mRNA-based Covid-19 vaccine, co-developed by BioNTech, below $10 (about Rs 730) a dose in India, sources close to the development indicated.
This could be the lowest price of the vaccine globally, and almost half the price in developed markets like the US, UK, and EU. “It is a single-digit price per dose,” a source said. “This is a not-for-profit price for the government’s immunisation programme.”
Covaxin Phase-3 efficacy analysis to be made public by July: Bharat Biotech
Covaxin manufacturer Bharat Biotech said that the detailed analysis of the phase-3 clinical trial data of its Covid-19 vaccine will be made public by July.
The company is also doing phase-4 trials for the real-world effectiveness of vaccines, reports said.
In a series of tweets, Raches Ella, project lead, Covid19 vaccines at Bharat Biotech said that the last volunteer of their phase-3 clinical trial (sample size 25,800) was vaccinated in mid-March. Read More
Four days after the Ministry of Electronics and Information Technology gave Twitter "one last notice" to comply with the newly notified Information Technology Rules, 2021, Twitter said it was making every effort to comply with the new guidelines and will provide the details of its Chief Compliance Officer within a week.
“We understand the importance of these regulations and have endeavored in good faith to comply with the Guidelines, including with respect to hiring personnel in India,” the US-headquartered firm has said in its reply. Read More
Amazon to Reliance Retail's Ajio, retailers roll out goodies for shoppers
It’s discount time. With non-essential retail now allowed to operate in the key metros, shoppers can expect massive discounts on everything from iPhones to track pants because the mid-year sales have been advanced by a month.
Amazon, Myntra and Reliance Retail’s Ajio have already begun to roll out their offers from this week.
Fashion and apparel e-tailer Myntra is organising a mid-year sale between June 12 and 16 with 40-70 per cent discounts. Additional discounts and cashback offers with lenders have been chalked out to sweeten the deals further. Read More
As the Reserve Bank of India (RBI) continues hoarding the benchmark 10-year bond, the security's shortage in the market is giving rise to some unique challenges.
It is not the most-traded paper anymore, but more importantly, say bond dealers, the 10-year bond is no longer the rate signal for the economy.
The US will buy 500 million more doses of the Pfizer Covid-19 vaccine to share through the global Covax alliance for donation to 92 lower income countries and the African Union over the next year, a person familiar with the matter said Wednesday.
President Joe Biden was set to make the announcement Thursday in a speech before the start of Group of Seven summit. Read More
Dear Reader,
Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.
As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.
Support quality journalism and subscribe to Business Standard.
Digital Editor
RECOMMENDED FOR YOU